the FDA also notes these reports are likely underreported because state-licensed 503A pharmacies are generally not required to submit adverse events to FDA
Adipose biology and obesity research robust reductions in adipocyte size and white-adipose mass in DIO mice without changes in food intake a phenotype distinct from any approved anti-obesity mechanism [2]
Increased Mental Health Disorder Symptoms For individuals with mental health conditions like depression or anxiety, alcohol may initially provide a sense of relaxation and calmness
Furthermore, owing to the single-blind design, these results should not be treated as evidence of symptomatic or disease-modifying efficacy of exenatide [17]
In response, some individuals explore microdosing as a way to improve tolerability, manage side effects, and create a more sustainable experience with GLP-1 therapy
Diabetes, Obesity and Metabolism, 24(1)